Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    8 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated primary completion date for the study on elranatamab versus lenalidomide in patients with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant.
    Difference
    0.0%
    Check dated 2024-05-10T08:51:27.000Z thumbnail image
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 04 30 04 29 04 30 has recently changed to 05 08 05 06 (Estimated) 05 08. This change likely represents an update or new information related to the clinical trial study involving elranatamab monotherapy compared to lenalidomide monotherapy in patients with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant.
    Difference
    0.3%
    Check dated 2024-05-09T06:25:30.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated primary completion date for the study involving elranatamab versus lenalidomide in patients with newly diagnosed multiple myeloma after transplant.
    Difference
    0.0%
    Check dated 2024-05-02T05:29:04.000Z thumbnail image
  8. Check
    18 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T23:14:31.000Z thumbnail image

Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.